Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jun 13;3(1):87-90.
doi: 10.1159/000353175. eCollection 2013.

Rosuvastatin-induced acute interstitial nephritis

Affiliations
Case Reports

Rosuvastatin-induced acute interstitial nephritis

Francesco Londrino et al. Case Rep Nephrol Urol. .

Abstract

We report a case of acute interstitial nephritis (AIN), most likely induced by rosuvastatin, in an 83-year-old male patient. The patient underwent angioplasty of the left internal carotid artery, after which he began a regimen of rosuvastatin (20 mg/day). After 3 weeks the patient was admitted to our unit for acute renal failure with mild proteinuria with negligible urinary sediment. A left kidney biopsy showed dense interstitial infiltrates, mainly composed of lymphocytes with evident tubulitis. Rosuvastatin withdrawal plus prednisolone (1 mg/kg/day) treatment, which was slowly tapered over a period of 4 weeks, allowed for a complete recovery of renal function. To our knowledge, this is the first case report of rosuvastatin-induced AIN. Acute renal failure is associated with a clear increase in morbidity, length of hospital stay and mortality. Moreover, since statins are among the most widely prescribed drugs in Western countries, we think that the risk of AIN should be taken into account as a possible side effect of rosuvastatin.

Keywords: Acute interstitial nephritis; Acute kidney injury; Rosuvastatin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Light microscopy with hematoxylin and eosin stain showing AIN with diffuse interstitial infiltrate and many lymphocytes associated to tubulitis (yellow arrow) in the presence of an uninvolved glomerulus (black arrow).

References

    1. Bays H. Statin safety: an overview and assessment of the data – 2005. Am J Cardiol. 2006;97:6C–26C. - PubMed
    1. FDA Advisory Committee Meeting: CRESTOR (ZD4522, rosuvastatin calcium) TABLETS. Briefing Document NDA 21-366 for the Use of CRESTOR. 2003; US Food and Drug Administration, www.fda.gov
    1. Agarwal R. Statin induced proteinuria: renal injury or renoprotection? J Am Soc Nephrol. 2004;15:2502–2503. - PubMed
    1. Bianchi S, Bigazzi R, Caiazza A, Campese VM. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis. 2003;41:565–570. - PubMed

Publication types

LinkOut - more resources